CF Industries Holdings Inc (CF)       87.41  +0.59 (+0.68%)

87.41  +0.59 (+0.68%)

US1252691001 - Common Stock


Fundamental Rating

We assign a fundamental rating of 6 out of 10 to CF. CF was compared to 123 industry peers in the Chemicals industry. CF has a great profitability rating, but there are some minor concerns on its financial health. CF is valued quite cheap, while showing a decent growth score. This is a good combination!




Profitability

Profitability Rating


CF's Return On Assets of 11.96% is amongst the best returns of the industry. CF outperforms 85% of its industry peers. The industry average Return On Assets is 4.55%.
CF's Return On Equity of 41.20% is amongst the best returns of the industry. CF outperforms 86% of its industry peers. The industry average return on equity is 16.51%.

CF has a Profit Margin of 19.73%. This is amongst the best returns in the industry. The industry average is 7.36%. CF outperforms 92% of its industry peers.
The Piotroski-F score of CF is 9.00. This is a very strong score and indicates great health and profitability for CF.
VS Industry

ROA (11.96%) VS Industry: 85% outperformed.

-168.20
35.03

ROE (41.2%) VS Industry: 86% outperformed.

0.51
216.50

Profit Margin (19.73%) VS Industry: 92% outperformed.

-48,500.00
91.93

Valuation

Valuation Rating


The Price/Earnings Ratio is 11.25, which indicates a very decent valuation of CF.
With a Forward Price/Earnings Ratio of 6.69, the valuation of CF can be described as cheap.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
When comparing the Enterprise Value to EBITDA ratio of CF to the average industry ratio of 8.19, CF is valued rather cheaply. CF is also cheaper than 86% of the companies listed in the same industry.

Compared to an average industry Price/Earning Ratio of 12.02, CF is valued in line with its industry peers.
When comparing the current price to the book value of CF, we can conclude it is valued correctly. It is trading at 4.56 times its book value.
When comparing the price book ratio of CF to the average industry price book ratio of 2.02, CF is valued more expensive than its industry peers. 82% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (11.25) VS Industry: 56% outperformed.

67.51
1.34

Price/Book (4.56) VS Industry: 18% outperformed.

1,035.49
0.01

Enterprise Value/ EBITDA (4.07) VS Industry: 86% outperformed.

75.67
0.47

Growth

Growth Rating


The Earnings Per Share has grown by an impressive 302.59% over the past year.
Measured over the past 5 years, CF shows a very strong growth in Earnings Per Share. The EPS has been growing by 55.62% on average per year.
CF shows a strong growth in Revenue. In the last year, the Revenue has grown by 98.95%.
The Revenue has been growing by 12.15% on average over the past 5 years. This is quite good.

CF is expected to show a decrease in Earnings Per Share. In the coming 5 years, the EPS will decrease by -5.20% yearly.
Based on estimates for the next 5 years, CF will show a decrease in Revenue. The Revenue will decrease by -8.94% on average per year.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS55.62% 52.48% 302.59% 347.74% 74.54% 23.35% -5.2%
Revenue12.15% 13.86% 98.95% 82.69% 19.89% 2.76% -8.94%

Health

Health Rating


CF has a very good Piotroski-F score of 9.00. This indicates a great health and profitability for CF.
A Current Ratio of 1.72 indicates that CF should not have too much problems paying its short term obligations.
CF has a Quick Ratio of 1.50. This is a normal value and indicates that CF is financially healthy and should not expect problems in meeting its short term obligations.
The Quick Ratio is in line with the industry averages, which is at 1.31.

An Altman-Z score of 2.85 indicates that CF is not a great score, but indicates only limited risk for bankruptcy at the moment.
CF has a Altman-Z score comparable to the industry average, which is at 2.79.
When comparing the Current Ratio of CF to the average industry Current Ratio of 1.97, CF is less able to pay its short term obligations than its industry peers.
When comparing the Debt to Equity Ratio of CF to the average industry Debt to Equity Ratio of 0.52, CF required more debt to finance its operations than its industry peers.
VS Industry

Debt/Equity (0.74) VS Industry: 37% outperformed.

8.24
-4.23

Quick Ratio (1.5) VS Industry: 59% outperformed.

0.00
61.90

Current Ratio (1.72) VS Industry: 38% outperformed.

0.00
61.90

Altman-Z (2.85) VS Industry: 52% outperformed.

-251.54
248.04

Dividend

Dividend Rating


15.71% of the earnings are spent on dividend by CF. This is a low number and sustainable payout ratio.
CF has paid a dividend for at least 10 years, which is a reliable track record.
With a Yearly Dividend Yield of 1.76%, CF has a reasonable but not impressive dividend return.

Compared to an average industry Dividend Yield of 2.32, CF is paying slightly less dividend.
CF's Dividend Yield is slightly below the S&P500 average, which is at 2.39.
VS Industry

Dividend Yield (1.76%) VS Industry: 37% outperformed.

0.34
18.27
CF Daily chart

CF Industries Holdings Inc87.41

NYSE:CF (6/28/2022, 11:17:10 AM)+0.59 (+0.68%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Chemicals
Earnings (Last) 05-04 2022-05-04/amc Earnings (Next) 08-01 2022-08-01
Ins Owners 0.5% Inst Owners 193.21%
Market Cap 18.23B Analysts 76.3
Valuation
PE 11.25 Fwd PE 6.69
PEG (NY) 0.03 PEG (5Y) 0.2
P/S 2.18 P/B 4.56
EV/EBITDA 4.07
Profitability
ROA 11.96% ROE 41.2%
PM 19.73 Asset Turnover 0.61
Growth
EPS 1Y 302.59% EPS 3Y 52.48%
EPS 5Y 55.62% EPS growth Q2Q 476.71%
EPS Next Y 347.74% EPS Next 2Y 74.54%
EPS Next 3Y 23.35% EPS Next 5Y -5.2%
Revenue growth 1Y 98.95% Revenue growth 3Y 13.86%
Revenue growth 5Y 12.15% Revenue growth Q2Q 173.66%
Revenue Next Year 82.69% Revenue Next 2Y 19.89%
Revenue Next 3Y 2.76% Revenue Next 5Y -8.94%
Health
Current Ratio 1.72 Quick Ratio 1.5
Altman-Z 2.85 F-Score 9
Debt/Equity 0.74
Dividend
Dividend Yield 1.76% Dividend Growth 0%
DP 15.71% Ex-Date 05-13 2022-05-13 (0.4)

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA